Illinois Ventures’ mission is to make the world a better, healthier and more accessible place through return-focused seed and early investment in healthcare and technology. We work with others to create a thriving entrepreneurial community in the University of Illinois system, University alumni networks, the Midwest, and the national venture capital market.
Illinois Ventures is committed to helping entrepreneurs and technical founders build world-changing businesses with the potential to create new market opportunities or significantly expand existing footholds. The vision for Illinois Ventures is to go beyond just providing capital by making Illinois a better and more vibrant place to do business.
Illinois Ventures is committed to helping entrepreneurs and technical founders build world-changing businesses with the potential to create new market opportunities or significantly expand existing footholds. The vision for Illinois Ventures is to go beyond just providing capital by making Illinois a better and more vibrant place to do business.
Location: United States, Illinois, Chicago
Employees: 11-50
Founded date: 2000
Investment Type: Venture Capital
Portfolio 27
| Date | Name | Website | Total Raised | Location |
| - | Tiesta Tea | tiestatea.com | - | - |
| - | Xaptum | xaptum.com | $3.1M | United Sta... |
| - | GlucoSenti... | glucosentient.com | - | - |
| - | REVOLUTION... | revmed.com | $100M | United Sta... |
| - | KeyWise AI | keywise.tech | - | - |
| - | Autonomic ... | autonomicmaterials.com | $3M | United Sta... |
| - | Brink Biol... | brinkbiologics.com | - | United Sta... |
| - | PharmaIN C... | pharmain.com | - | - |
| - | thindiamond.com | - | United Sta... | |
| - | Gust | gust.com | - | - |
Show more
Mentions in press and media 13
| Date | Title | Description |
| 22.06.2026 | Syntax Bio Raises $14.4 Million Series A And Announces Leadership Appointments | Syntax Bio announced an expanded Series A round and several leadership appointments across its executive team, board of directors, and scientific advisory board. The expanded round brings Syntax Bio’s Series A to $14.4 million and total fun... |
| 22.06.2026 | Syntax Bio Expands Series A to $14.4M | Syntax Bio, a Chicago, IL-based synthetic biology company programming new cell therapies, expanded its Series A to $14.4M. The expanded round saw participation from Astellas Venture Management, Illumina Ventures, DCVC Bio, Civilization Vent... |
| 28.06.2024 | Elion Therapeutics: $81 Million Closed To Transform Treatment Of Life-Threatening Invasive Fungal Infections | Elion Therapeutics, a biotechnology company focused on transforming the treatment of life-threatening invasive fungal infections (IFIs), announced it has closed a $81 million Series B funding round led by Deerfield Management and the AMR Ac... |
| 17.06.2024 | Elion Therapeutics Closes $81M Series B Funding Round | Elion Therapeutics, a NYC-based biotechnology company dedicated to advancing the treatment of life-threatening invasive fungal infections (IFIs), closed a $81M Series B funding. The round was led by Deerfield Management and the AMR Action F... |
| 31.08.2022 | Why The University Of Illinois Is A Top College For Entrepreneurs | The University of Illinois has an incredible history of producing world-class startups and cutting-edge technologies. The university is also renowned for cultivating bright, purpose first entrepreneurs who are making a positive impact on th... |
| 14.09.2015 | 10 Chicago VC Firms You Need to Know About | Chicago is usually towards the top of the list when it comes to startup hubs in the United States. It's no surprise that Tech.Co had its first events in that city, (back when we were simply known as Tech Cocktail), providing demo space and ... |
| 13.01.2015 | Research Projects at 3 Illinois Universities Get Funding From IllinoisVentures | Researchers from three universities in Illinois have received the first batch of funding from IllinoisVentures, a University of Illinois-born fund that aims to accelerate the commercialization of new technologies. Five researchers from the ... |
| 06.02.2012 | Targeted drug hopes to have success attacking multiple cancers | In preclinical studies, the compounds were well tolerated and efficacious in mice. One clinical candidate, VO-101, also stabilized or reduced tumor size in dogs with metastatic disease, which Hergenrother said better mimics the course of ac... |
| 26.09.2011 | Advanced imaging startup Diagnostic Photonics raises $1.3M investment | The company says its imaging technology is designed to help doctors evaluate diseased tissue during surgery by visualizing tissue “at the microscopic level.” Diagnostic Photonics calls its core technology “interferometric synthetic aperture... |
| 25.02.2010 | Never Mind the Valley: Here’s Chicago | Holding down the proverbial fort for the mid-west, Chicago, the Windy City, is the third largest city in the U.S. and the most populous city that doesn’t sit on an ocean coast. The city, which does, however, rest on the shore of Lake Michig... |
Show more